Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eletriptan vs Sumatriptan for Acute Migraine Treatment
NCT01986088Phase 3Completed
- Sponsor
- Viatris
- Start
- Nov 1996
- Primary completion
- Jan 1998
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of eletriptan in migraine (5 arms), sponsored by Viatris. Primary endpoint: Headache response at 1 hour after treatment of the first attack. Started Nov 1996; status: completed.
02
Drugs
eletriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01986088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986088.